文献速递妇科

ROR1与ROR2在子宫内膜癌中发挥不同且相反的作用

ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2018-02-01

研究在子宫内膜癌患者队列中免疫组化检测ROR1与ROR2表达并分析其与临床病理参数及生存的相关性,同时在KLE、RL95-2和MFE-319三种细胞系中通过siRNA敲低两受体观察增殖、黏附、迁移和侵袭变化。结果显示ROR1高表达与更差总生存相关,ROR2高表达与更好总生存相关,敲低实验提示ROR1可能促进肿瘤进展而ROR2在子宫内膜样癌中可能起抑癌作用,作者认为这些受体有潜力作为治疗靶点。

要点

  • 患者样本中ROR1高表达与更差总生存相关(p=0.0169)。
  • 患者样本中ROR2高表达与更好总生存相关(p=0.06)。
  • 敲低实验提示ROR1可能促进、ROR2可能抑制子宫内膜癌进展。

核心结论

  • ROR1与ROR2在子宫内膜癌中发挥不同作用,ROR1可能促进肿瘤进展,ROR2在子宫内膜样子宫内膜癌中可能作为抑癌因子。
  • 作者认为,鉴于多种靶向ROR的疗法正在开发中且已在其他肿瘤类型开展I期临床试验,本研究支持这些受体作为子宫内膜癌女性治疗靶点的潜力。

研究设计与样本

  • 对患者队列进行ROR1与ROR2免疫组化,并将表达与类型、分期、分级、肌层浸润、淋巴血管受累、患者年龄和生存等临床病理参数进行相关性分析。
  • 在KLE、RL95-2和MFE-319三种细胞系模型中通过siRNA敲低ROR1和ROR2,检测对增殖、黏附、迁移和侵袭的影响。

主要发现

  • 患者样本中ROR1高表达与更差总生存相关(p=0.0169),ROR2高表达与更好总生存相关(p=0.06)。
  • KLE细胞中敲低ROR1显著降低增殖(p=0.047),并减少迁移和侵袭。
  • RL95-2细胞中敲低ROR2增加细胞迁移和侵袭(p=0.011)。
  • MFE-319细胞中同时敲低ROR1和ROR2降低黏附,并显著增加细胞迁移(P=0.008)和侵袭(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In recent years, the Wnt signalling pathway and the ROR1 and ROR2 receptors have been implicated in a range of gynecological cancers. These receptors have been described as prospective therapeutic targets, and this study investigated such potential in an endometrial cancer context. METHOD: Immunohistochemistry for ROR1 and ROR2 was performed in a patient cohort, and expression was correlated with clinicopathological parameters including type, stage, grade, myometrial invasion, lymphovascular involvement, patient age and survival. The functional role of these receptors in endometrial cancer was investigated via siRNA knockdown of ROR1 and ROR2 in three cell line models (KLE, RL95-2 and MFE-319). Effects on proliferation, adhesion, migration and invasion were measured. RESULTS: High ROR1 expression in patient samples correlated with worse overall survival (p = 0.0169) while high ROR2 expression correlated with better overall survival (p = 0.06). ROR1 knockdown in KLE cells significantly decreased proliferation (p = 0.047) and reduced migration and invasion. ROR2 knockdown in RL95-2 cells increased cell migration and invasion (p = 0.011). Double ROR1 and ROR2 knockdown in MFE-319 cells decreased adhesion and significantly increased cell migration (P = 0.008) and invasion (p < 0.001). CONCLUSION: ROR1 and ROR2 play distinct roles in endometrial cancer. ROR1 may promote tumor progression, similar to its role in ovarian cancer, while ROR2 may act as a tumor suppressor in endometrioid endometrial cancer, similar to its role in colorectal cancer. With several ROR-targeting therapies currently in development and phase I clinical trials for other tumor types, this study supports the potential of these receptors as therapeutic targets for women with endometrial cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Henry CE, Llamosas E, Daniels B, et al. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. Gynecol Oncol. 2018. PMID: 29395309. doi:10.1016/j.ygyno.2018.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。